Neltenexine tablets in smoking and non-smoking patients with COPD. A double-blind, randomised, controlled study versus placebo

Minerva Medica

Volumn 92, Issue 4, 2001, Pages 277-284

  Cattaneo, C ^a  

^a Servizio Pneumotisiologia   (Italy)

Author keywords

Expectorants; Lung diseases, obstructive, drug therapy; Neltenexine; Smoking

Indexed keywords

ALVEOTEN; MUCOLYTIC AGENT; NELTENEXINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; SMOKING; SPUTUM ANALYSIS; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; AMBROXOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TABLETS;

EID: 0034783417     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Prevalence rates of respiratory symptoms in Italian general population samples exposed to different levels of air pollution
2. Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
3. 1
4. Smoking, lung function and α-antitrypsin deficiency
5. 1. The lung health study
6. Mortality in relation to smoking: 40 Years observations on male British doctors
7. Guidelines for the management of chronic obstructive pulmonary disease
8. Domiciliary oxygen therapy
9. The natural history of chronic airflow obstruction
10. Mucoactive drugs in the management of chronic obstructive pulmunary disease
11. 1 decline and chronic obstructive pulmunary disease morbidity
12. Chronic mucous hypersecretion in COPD and death from pulmonary function
13. Is respiratory mucus hypersecretion really an innocent disorder?
14. Elastase and emphysema. Current assessment of the protease-antiprotease hypotesis
15. The relation of smoking and age to emphysema. Whole-lung section study
16. Pathogenesis of emphysema and chronic bronchitis
17. Neltenexine: Morphological investigation of protection against elastase-induced emphysema in rats
18. Bioavailability of neltenexine
19. Danni sul surfattante alveolare di topo causati da inalazioni acuta di fumo di sigaretta: Effetto protettivo di neltenexina
20. Danni sul surfattante alveolare di topo causati da inalazioni di ossigeno puro: Effetto protettivo di neltenexina
21. Relationship between changes in alveolar surfactant levels and lung defence mechanism
22. A doubleblind, randomised, controlled clinical trial versus placebo to evaluate the efficacy, tolerability and the activity on rheological parameters of neltenexine tablets in patients with COPD
23. Neltenexine with concomitant antibiotic therapy in exacerbations of chronic obstructive pulmonary disease: A double-blind, randomised, controlled study versus placebo